Dishman Pharmaceuticals and Chemicals Switzerland-based subsidiary Carbogen Amcis AG has acquired Creapharm Parenterals for an undisclosed amount. As part of this acquisition, Creapharm Parenterals, a contract development and manufacturing firm, has changed its name to Carbogen Amics SAS. The acquisition will extend Carbogen Amics development and manufacturing services by adding complementary formulation and lyophilisation services and sterile GMP capabilities for the fast supply of drug products, including highly potents, for pre-clinical studies and clinical trials (Phase I, II & III).
